A detailed history of Heritage Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Heritage Wealth Advisors holds 2,070 shares of BMY stock, worth $111,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,070
Previous 2,478 16.46%
Holding current value
$111,697
Previous $134,000 36.57%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $16,422 - $21,619
-408 Reduced 16.46%
2,070 $85,000
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $4,222 - $4,787
-88 Reduced 3.43%
2,478 $134,000
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $9,065 - $10,817
187 Added 7.86%
2,566 $131,000
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $11,751 - $13,140
-203 Reduced 7.86%
2,379 $138,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $2,229 - $2,475
-35 Reduced 1.34%
2,582 $165,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $14,324 - $16,247
-218 Reduced 7.69%
2,617 $181,000
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $47,936 - $56,763
700 Added 32.79%
2,835 $203,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $4 - $2,535
33 Added 1.57%
2,135 $152,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $4,647 - $5,118
-64 Reduced 2.95%
2,102 $162,000
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $104,516 - $125,324
-1,700 Reduced 43.97%
2,166 $158,000
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $92,246 - $108,054
-1,559 Reduced 28.74%
3,866 $228,000
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $45,751 - $49,823
-739 Reduced 11.99%
5,425 $362,000
Q2 2021

Jul 27, 2021

BUY
$61.91 - $67.42 $35,536 - $38,699
574 Added 10.27%
6,164 $382,000
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $34,061 - $38,308
-574 Reduced 9.31%
5,590 $352,000
Q4 2020

Feb 01, 2021

BUY
$57.74 - $65.43 $281,828 - $319,363
4,881 Added 380.44%
6,164 $382,000
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $40,201 - $44,548
-700 Reduced 35.3%
1,283 $77,000
Q2 2020

Jul 17, 2020

SELL
$54.82 - $64.09 $83,490 - $97,609
-1,523 Reduced 66.13%
780 $116,000
Q2 2020

Jul 17, 2020

BUY
$54.82 - $64.09 $65,948 - $77,100
1,203 Added 154.23%
1,983 $116,000
Q1 2020

May 05, 2020

BUY
$46.4 - $67.43 $22,040 - $32,029
475 Added 25.98%
2,303 $128,000
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $52,310 - $68,233
1,063 Added 138.95%
1,828 $117,000
Q3 2019

Oct 30, 2019

SELL
$42.77 - $50.71 $99,098 - $117,495
-2,317 Reduced 75.18%
765 $38,000
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $46,092 - $50,968
1,033 Added 50.41%
3,082 $0
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $5,461 - $7,081
-112 Reduced 5.18%
2,049 $106,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $119,265 - $134,522
2,161 New
2,161 $134,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.